Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688212's Current Ratio is ranked worse than 64.71% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 2.49
vs SHSE:688212: 1.87
Shanghai Aohua Photoelectricity Endoscope Co (SHSE:688212) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Shanghai Aohua Photoelectricity Endoscope Co Current Ratio Related Terms
Shanghai Aohua Photoelectricity Endoscope Co Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Aohua Photoelectricity Endoscope Co Current Ratio Chart
Shanghai Aohua Photoelectricity Endoscope Co Annual Data
SHSE:688212 vs ABT, SYK, MDT: Current Ratio Comparison
For the Medical Devices subindustry, Shanghai Aohua Photoelectricity Endoscope Co's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Aohua Photoelectricity Endoscope Co Current Ratio vs Medical Devices & Instruments Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Aohua Photoelectricity Endoscope Co (SHSE:688212) has a Current Ratio of 1.87 as of Mar. 2026. This is 70% below median its historical median of 6.25. Over the past decade, Shanghai Aohua Photoelectricity Endoscope Co's Current Ratio has ranged from 1.87 to 22.77. According to the industry distribution chart, Shanghai Aohua Photoelectricity Endoscope Co ranks #552 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 64.7%.
Is Shanghai Aohua Photoelectricity Endoscope Co's Current Ratio too high?
Shanghai Aohua Photoelectricity Endoscope Co's current Current Ratio of 1.87 is 70% below median its 10-year median of 6.25. Over the past 10 years, this metric has ranged from a low of 1.87 to a high of 22.77. The Medical Devices & Instruments industry median Current Ratio is 2.49. Shanghai Aohua Photoelectricity Endoscope Co's value of 1.87 is 24.9% below this industry median. Based on the distribution chart, Shanghai Aohua Photoelectricity Endoscope Co ranks #552 out of 853 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Shanghai Aohua Photoelectricity Endoscope Co has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Aohua Photoelectricity Endoscope Co's Current Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shanghai Aohua Photoelectricity Endoscope Co ranks #552 out of 853 companies for Current Ratio. This places Shanghai Aohua Photoelectricity Endoscope Co in the lower half of its industry. The industry median Current Ratio is 2.49. Shanghai Aohua Photoelectricity Endoscope Co's value of 1.87 is 24.9% below this benchmark. Historically, Shanghai Aohua Photoelectricity Endoscope Co's own Current Ratio has ranged from 1.87 to 22.77 over the past decade. While the company's 10-year median is 6.25 vs. the industry median of 2.49, Shanghai Aohua Photoelectricity Endoscope Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.49, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Aohua Photoelectricity Endoscope Co's current Current Ratio of 1.87 is 24.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Aohua Photoelectricity Endoscope Co's current Current Ratio is 1.87, which is 70% below median its own 10-year median of 6.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Aohua Photoelectricity Endoscope Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Aohua Photoelectricity Endoscope Co (SHSE:688212) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥61.99, compared to a current price of ¥25.37 — trading 59.1% below its estimated fair value. The current Current Ratio is 1.87, which is 70% below median its 10-year median of 6.25 and 24.9% below the Medical Devices & Instruments industry median of 2.49. Shanghai Aohua Photoelectricity Endoscope Co's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Shanghai Aohua Photoelectricity Endoscope Co (SHSE:688212), the current Current Ratio is 1.87 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Aohua Photoelectricity Endoscope Co (SHSE:688212) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Aohua Photoelectricity Endoscope Co stock appears to be undervalued.
The current stock price of ¥25.37 is trading 59.1% below its estimated GF Value™ of ¥61.99.
GuruFocus considers Shanghai Aohua Photoelectricity Endoscope Co to be Significantly Undervalued.
Key valuation signals for SHSE:688212:
Current Ratio: 1.87 (70% below median its 10-year median of 6.25)
GF Value™: ¥61.99 vs. price of ¥25.37 (59.1% below fair value)
Industry Position: 24.9% below the Medical Devices & Instruments median (#552 of 853)
No single metric tells the full story. See the SHSE:688212 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Aohua Photoelectricity Endoscope Co Business Description
Shanghai Aohua Photoelectricity Endoscope Co Ltd is engaged in the research and development, production and sales of electronic endoscope equipment and endoscope diagnostic and surgical consumables.
70GF Score
Get the complete analysis for SHSE:688212
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688212 has been successfully added to your 
